| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed686eb81674a74f0cfa1f1f18f54dad |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-582 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-58 |
| filingDate |
2015-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6996e6590b1787c708099c0ac803697 |
| publicationDate |
2017-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2017248616-A1 |
| titleOfInvention |
In vitro compositions comprising human sample and amyloid targeting agent |
| abstract |
Provided herein are compositions and methods useful for detection of amyloid related disorders in samples, such as human tissue, cell or body fluid. Use of the compositions and methods herein allows for the rapid, in vitro detection of amyloid accumulation, often before amyloid disorder symptoms are manifest or without introduction of foreign fluorophore molecules into a subject. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020093008-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021055639-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114195686-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11718596-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10934264-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022266210-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10370345-B2 |
| priorityDate |
2014-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |